Abstract
Metabolic disorders, including diabetes, obesity, and dyslipidemia, represent a significant global health challenge. Recent advancements in bioengineering have opened new avenues for the treatment and management of these disorders, offering innovative solutions that go beyond conventional pharmaceutical approaches. This article reviews the role of bioengineering in the development of novel therapeutic strategies for metabolic disorders, focusing on areas such as gene therapy, tissue engineering, biosensors, and personalized medicine. It also highlights the potential of bioengineering technologies in addressing the root causes of metabolic diseases, promoting long-term health, and improving quality of life.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2022 Dr. Emily Harris, Dr. Oliver Smith (Author)